The settlement would bring an end to the case filed by Pittsburgh-based West Penn Allegheny Health System, which is now owned by Highmark, against UPMC, accusing the health system of stifling competition. It would also dismiss UPMC’s similar lawsuit against Highmark.
Late last month, Highmark moved to include a clause in the settlement that would prevent UPMC from characterizing Highmark as “monopolistic” in litigation brought forth by third parties, including a pending suit in which four plaintiffs are accusing UPMC and Highmark of colluding to inflate prices. Last week, UPMC asked U.S. District Court Judge Joy Flowers Conti to enforce the settlement agreement reached in October without the added provision.
Highmark has asked Judge Conti to force UPMC to sign the new agreement, claiming UPMC “had no intention of fully dropping its misguided antitrust crusade against Highmark,” according to a Pittsburgh Business Times report.
A UPMC spokesperson said the health system is ready to sign a settlement, though refuses the current version because Highmark has “reneged on the agreement, attempted to add to terms regarding an entirely new subject matter that was never before the court,” according to the report.
More Articles on UPMC and Highmark:
UPMC Asks Judge to Enforce Initial Settlement With Highmark
UPMC, Highmark’s Tentative Settlement on the Rocks
UPMC, Highmark Reach Tentative Agreement to End 4-Year Antitrust Fight
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.